Union Bank of India has informed the Exchange about Loss of Share Certificates
Esab India Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Feb-2022.
Suven Pharmaceuticals Limited has informed the Exchange regarding Cessation of Mr Chandrasekhar Srivari as Non- Executive Independent Director of the company w.e.f. January 19, 2022.
DS Kulkarni Developers Limited has informed the Exchange regarding Intimation about filing of Corporate Governance Report pursuant to regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Shemaroo Entertainment Limited has informed the Exchange about Schedule of meet
Welspun India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Vikas Lifecare Limited has informed the Exchange about Copy of Newspaper Publication
Nakoda Group of Industries Limited has informed the Exchange about Copy of Newspaper Publication
Reliance Capital Limited has informed the Exchange about Loss of Share Certificates
SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 20, 2022, titled we are enclosing here with press release dated 20th January, 2022 regarding the Company receives non-exclusive license to manufacture and supply of molnupiravir (an oral COVID 19 medicine) through the medicine patent pool(MPP).

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.